Racial differences in the prevalence of diabetes but not diabetic retinopathy in a multi-ethnic asian population

Investigative Ophthalmology and Visual Science

Volumn 52, Issue 10, 2011, Pages 7586-7592

  Chiang, Peggy P C ^a,b   Lamoureux, Ecosse L ^a,c   Cheung, Carol Y ^a,b   Sabanayagam, Charumathi ^d   Wong, Wanling ^a   Shyong Tai, E ^e   Lee, Jeannette ^f   Wong, Tien Y ^a,c,e  

^a SINGAPORE EYE RESEARCH INSTITUTE   (Singapore)

^b DUKE NUS MEDICAL SCHOOL   (Singapore)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e NATIONAL UNIVERSITY HEALTH SYSTEM   (Singapore)

^f NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; HEMOGLOBIN A1C; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; ASIAN; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DIABETIC RETINOPATHY; DISEASE DURATION; EDUCATION; EYE FUNDUS; EYE PHOTOGRAPHY; FEMALE; HUMAN; MALE; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; RACE DIFFERENCE; RISK FACTOR; SYSTOLIC BLOOD PRESSURE; BLOOD; COMPARATIVE STUDY; ETHNIC GROUP; ETHNOLOGY; GLUCOSE BLOOD LEVEL; METABOLISM; MIDDLE AGED; SINGAPORE; STATISTICS;

ADULT; AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD GLUCOSE; CREATININE; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; DIABETIC RETINOPATHY; ETHNIC GROUPS; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS; SINGAPORE;

EID: 84863830751     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.11-7698     Document Type: Article

References (56)

1. World Health Organization. Diabetic Retinopathy. Available at: http://www.who.int/blindness/causes/priority/en/index6. html. Accessed November 1, 2010.
2. Saaddine JB, Honeycutt AA, Narayan KMV, Zhang XZ, Klein R, Boyle JP. Projection of diabetic retinopathy and other major eye diseases among people with diabetes mellitus United States 2005-2050. Arch Ophthalmol. 2008;126(12):1740-1747.
3. Frank RN. Diabetic retinopathy. N Engl J Med. 2004;350(1):48-58.
4. Mohamed Q, Gillies MC, Wong TY. Management of diabetic retinopathy: a systematic review. JAMA. 2007;298(8)902-916.
5. Cheung N, Mitchell P, Wong TY. Diabetic retinopathy. Lancet. 2010;376(9735):124-136.
6. Zhang XZ, Saaddine JB, Chou CF, et al. Prevalence of diabetic retinopathy in the United States 2005-2008. JAMA. 2010;304(6):649-656.
7. Congdon NG, Friedman DS, Lietman T. Important causes of visual impairment in the world today. JAMA. 2003;290(15):2057-2060.
8. Fong DS, Aiello LP, Ferris FL, Klein R. Diabetic retinopathy. Diabetes Care. 2004;27(10):2540-2553.
9. Harris MI, Eastman RC, Cowie CC, Flegal KM, Eberhardt MS. Racial and ethnic differences in glycemic control of adults with type 2 diabetes. Diabetes Care. 1999;22(3):403-408.
10. Narayan KMV, Boyle JP, Thompson TJ, Sorensen SW, Williamson DF. Lifetime risk for diabetes mellitus in the United States. JAMA. 2003;290(14):1884-1890.
11. McBean AM, Li SL, Gilbertson DT, Collins AJ. Differences in diabetes prevalence, incidence, and mortality among the elderly of four racial/ethnic groups: whites, blacks, Hispanics, and Asians. Diabetes Care. 2004;27(10):2317-2324.
12. Harris MI, Klein R, Cowie CC, Rowland M, Byrd-Holt DD. Is the risk of diabetic retinopathy greater in non-Hispanic blacks and Mexican Americans than in non-Hispanic whites with type 2 diabetes?-a US population study. Diabetes Care. 1998;21(8):1230-1235.
13. LaVeist TA, Thorpe RJ, Galarraga JE, Bower KM, Gary-Webb TL. Environmental and socio-economic factors as contributors to racial disparities in diabetes prevalence. J Gen Intern Med. 2009;24(10):1144-1148.
14. Munoz B, West SK, Rubin GS, et al. Team SEES. Causes of blindness and visual impairment in a population of older Americans: the Salisbury Eye Evaluation Study. Arch Ophthalmol. 2000;118(6):819-825.
15. Varma R, Torres M, Pena F, Klein R, Azen SP. Los Angeles Latino Eye Study. Prevalence of diabetic retinopathy in adult Latinos: The Los Angeles Latino Eye Study. Ophthalmology. 2004;111(7):1298-1306.
16. Dowse GK, Humphrey ARG, Collins VR, et al. Prevalence and risk factors for diabetic retinopathy in the multiethnic population of Mauritius. Am J Epidemiol. 1998;147(5):448-457.
17. Wong TY, Cheung N, Tay WT, et al. Prevalence and risk factors for diabetic retinopathy the Singapore Malay Eye Study. Ophthalmology. 2008;115(11):1869-1875.
18. Liang YB, Friedman DS, Wong TY, et al. Rationale, design, methodology, and baseline data of a population-based study in rural China: The Handan Eye Study. Ophthalmic Epidemiol. 2009;16(2):115-127.
19. Wang FH, Liang YB, Zhang F, et al. Prevalence of diabetic retinopathy in rural China: The Handan Eye Study. Ophthalmology. 2009; 116(3):461-467.
20. Andrulis DP. Access to care is the centerpiece in the elimination of socioeconomic disparities in health. Ann Intern Med. 1998; 129(5):412-416.
21. Cooper LA, Hill MN, Powe NR. Designing and evaluating interventions to eliminate racial and ethnic disparities in health care. J Gen Intern Med. 2002;17(6):477-486.
22. Wu Y, Tai ES, Heng D, Tan CE, Low LP, Lee J. Risk factors associated with hypertension awareness, treatment, and control in a multi-ethnic Asian population. J Hypertens. 2009;27(1):190-197.
23. Cutter J, Tan BY, Chew SK. Levels of cardiovascular disease risk factors in Singapore following a national intervention programme. Bull World Health Org. 2001;79(10):908-915.
24. Hughes K, Aw TC, Kuperan P, Choo M. Central obesity, insulin resistance, syndrome X, lipoprotein (a), and cardiovascular risk in Indians, Malays, and Chinese in Singapore. J Epidemiol Community Health. 1997;51(4):394-399.
25. Hughes K, Yeo PPB, Lun KC, et al. Cardiovascular-diseases in Chinese, Malays, and Indians in Singapore: 2. differences in risk factor levels. J Epidemiol Community Health. 1990;44(1):29-35.
26. Tan CE, Emmanuel SC, Tan BY, Jacob E. Prevalence of diabetes and ethnic differences in cardiovascular risk factors: the 1992 Singapore National Health Survey. Diabetes Care. 1999;22(2):241-247.
27. Jeganathan VSE, Sabanayagam C, Tai ES, et al. Retinal vascular caliber and diabetes in a multiethnic Asian population. Microcirculation. 2009;16(6):534-543.
28. Klein R, Klein BEK, Magli YL, et al. An alternative method of grading diabetic-retinopathy. Ophthalmology. 1986;93(9):1183-1187.
29. Grading diabetic retinopathy from stereoscopic color fundus photographs-an extension of the modified Airlie House classification. ETDRS Report Number 10. Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology. 1991;98(5 suppl):786-806.
30. Singapore Department of Statistics. Census of Population 2010 Advance Census Release. Singapore: Ministry of Trade and Industry; 2010.
31. Xie XW, Xu L, Jonas JB, Wang YX. Prevalence of diabetic retinopathy among subjects with known diabetes in China: The Beijing Eye Study. Eur J Ophthalmol. 2009;19(1):91-99.
32. Dandona L, Dandona R, Naduvilath TJ, McCarty CA, Rao GN. Population based assessment of diabetic retinopathy in an urban population in Southern India. Br J Ophthalmol. 1999;83(8):937-940.
33. Narendran V, John RK, Raghuram A, Ravindran RD, Nirmalan PK, Thulasiraj RD. Diabetic retinopathy among self reported diabetics in Southern India: a population based assessment. Br J Ophthalmol. 2002;86(9):1014-1018.
34. Eberhardt MS, Lackland DT, Wheeler FC, German RR, Teutsch SM. Is race related to glycemic control: an assessment of glycosylated hemoglobin in 2 South-Carolina communities. J Clin Epidemiol. 1994;47(10):1181-1189.
35. Mouton DP, Gill AJ. Prevalence of diabetic-retinopathy and evaluation of risk-factors: a review of 1005 diabetic clinic patients. South Afr Med J. 1988;74(8):399-402.
36. Wong TY, Klein R, Islam A, et al. Diabetic retinopathy in a multiethnic cohort in the United States. Am J Ophthalmol. 2006;141(3): 446-455.
37. Bunce C, Wormald R. Leading causes of certification for blindness and partial sight in England and Wales. BMC Public Health. 2006;6:58.
38. Rema M, Pradeepa R. Diabetic retinopathy: an Indian perspective. Indian J Med Res. 2007;125(3):297-310.
39. Raymond NT, Varadhan L, Reynold DR, et al. Higher prevalence of retinopathy in diabetic patients of South Asian ethnicity compared with white Europeans in the community: a cross-sectional study. Diabetes Care. 2009;32(3):410-415.
40. Harris EL, Feldman S, Robinson CR, Sherman S, Georgopoulos A. Racial-differences in the relationship between blood-pressure and risk of retinopathy among individuals with NIDDM. Diabetes Care. 1993;16(5):748-754.
41. Lim A, Stewart J, Chui TY, et al. Prevalence and risk factors of diabetic retinopathy in a multi-racial underserved population. Ophthalmic Epidemiol. 2008;15(6):402-409.
42. Cohen RM, Haggerty S, Herman WH. Hba1c for the diagnosis of diabetes and prediabetes: is it time for a mid-course correction? J Clin Endocrinol Metabolism. 2010;95(12):5203-5206.
43. Wanic K, Pazderska A, Shah S, et al. Early onset type 2 diabetes subjects have a metabolic signatures distinguishing them from BMI-matched normoglycaemic individuals. Irish J Med Sci. 2010;179:517-517.
44. Tavintharan S, Cheung N, Lim SC, et al. Prevalence and risk factors for peripheral artery disease in an Asian population with diabetes mellitus. Diabetes Vasc Dis Res. 2009;6(2):80-86.
45. Hiatt WR, Hoag S, Hamman RF. Effect of diagnostic-criteria on the prevalence of peripheral arterial-disease: the San-Luis Valley Diabetes Study. Circulation. 1995;91(5):1472-1479.
46. von Eckardstein A, Sibler RA. Possible Contributions of lipoproteins and cholesterol to the pathogenesis of diabetes mellitus type 2. Curr Opin Lipidol. 2011;22(1):26-32.
47. Pradeepa R, Anjana RM, Unnikrishnan R, Ganesan A, Mohan V, Rema M. Risk factors for microvascular complications of diabetes among South Indian subjects with type 2 diabetes: The Chennai Urban Rural Epidemiology Study (CURES) Eye Study 5. Diabetes Technol Ther. 2010;12(10):755-761.
48. Makinen VP, Forsblom C, Thorn LM, et al. Network of vascular diseases, death and biochemical characteristics in a set of 4,197 patients with type 1 diabetes (the Finndiane Study). Cardiovasc Diabetol. 2009;8:10.
49. Shamoon H, Duffy H, Fleischer N, et al. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329(14):977-986.
50. Turner RC, Holman RR, Cull CA, et al. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) (published correction in Lancet. 1999;354:602). Lancet 1998;352:837-852.
51. Stearne MR, Palmer SL, Hammersley MS, et al. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ. 1998;317(7160):703-713.
52. Klein R, Klein BE, Moss SE, Davis MD, DeMets DL. The Wisconsin Epidemiologic Study of Diabetic Retinopathy: III, prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol. 1984;102(4):527-532.
53. Sabanayagam C, Shankar A, Koh D, et al. Retinal microvascular caliber and chronic kidney disease in an Asian population. Am J Epidemiol. 2009;169(5):625-632.
54. Wong TY, Shanhar A, Klein R, Klein BEK, Hubbard LD. Retinal arteriolar narrowing, hypertension, and subsequent risk of diabetes mellitus. Arch Intern Med. 2005;165(9):1060-1065.
55. Abdollahi A, Moghimi S, Tabasi A, Rajabi MT, Sabet B. Neuropathy and retinopathy in diabetes: is there any association? Int J Ophthalmol. 2009;2(1):57-60.
56. Cohen J. Statistical Power Analysis for the Behavioral Sciences. Hillsdale, NJ: Lawrence Erlbaum Associates; 1988.